Granisetron Hydrochloride - CAS# 107007-99-8 10549 Several clinical trials were conducted

Several clinical trials were conducted

the target protein is polyubiquitinated by IAPs

while tumors derived from control rats weighed 114±13 mg (32% reduction

75% of total content with 10 μM 22 vs 8

The activation of AMPK inhibits mTOR signaling

Granisetron Hydrochloride - CAS# 107007-99-8 10549 Several clinical trials were conductedGranisetron hydrochloride is the hydrochloride salt of an indazole derivative with antiemetic properties. As a selective serotonin receptor antagonist, granisetron competitively blocks the action of serotonin at 5 hydroxytryptamine3 (5 HT3) receptors, resulting in the suppression of chemotherapy and radiotherapy induced nausea and vomiting. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus). Product